Dr. Barry Dworkin

This Drug Wiped Out All Cancer Markers in 78% of High-Risk Patients With Smoldering Multiple Myeloma– Before They Even Got Cancer

Medical Mythbusting Commentary for September 22, 2026

Source:
This Drug Wiped Out All Cancer Markers in 78% of High-Risk Patients – Before They Even Got Cancer

Reference:
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial

Related posts:

  1. Genes research offers cancer treatment hope
  2. Vaccine implant destroys cancer tumours in mice
  3. New experimental technique may reduce bone marrow transplant rejections
  4. Drug combo boosts advanced HER-2 breast cancer survival